Abstract:Objective To evaluate the value of fetal echocardiography for the prenatal diagnosis of congenital heart disease.Methods A search in Cochrane Library,PubMed,OVID,Springer,China National Knowledge Infrastructure (CNKI),Wanfang Chinese Periodical Database and Chinese Bio-medicine Database(CBM)was performed to identify relevant English and Chinese language articles from Jan 1990 to Jan 2009. Inclusion criteria were established based on validity criteria for diagnostic research. Subsequently,the characteristics of the included articles were extracted. Statistical analysis was performed by employing Meta-DiSc 1.4 and SPSS 12.0 software. Heterogeneity of the included articles was tested,which was used to select proper effect model to calculate pooled weighted sensitivity and specificity. Summary receiver operating characteristic (SROC) curve was made and the area under the curve (AUC) was calculated. Finally,sensitivity analysis was performed. Results Eighteen articles were included,with a total of 77 939 fetuses. Seven articles meeting with inclusion criteria were analyzed for the value of basic cardiac echocardiographic examination (BCEE) for the prenatal diagnosis of congenital heart disease. The pooled sensitivity and specificity were 41.7% and 99.9% respectively,AUC=0.978 7. Twelve articles meeting with inclusion criteria were analyzed for the value of extended cardiac echocardiographic examination (ECEE). The pooled sensitivity and specificity were 66.9% and 99.9% respectively,AUC=0.995 6. The sensitivity of ECEE was significantly higher than that of BCEE(χ2=63.93,P0.05).The random-effect model was used in the analysis because of the heterogeneity. The layering research and sensitivity analysis were performed on the BCEE and ECEE. The sensitivity of BCEE and ECEE for the prenatal diagnosis of congenital heart disease during the second to third trimester was significantly higher than that during the second trimester(χ2= 5.47,39.37,P0.05);The sensitivity of ECEE for the prenatal diagnosis of congenital heart disease for the fetuses of low-risk pregnant women was lower than that of the unselected or high-risk pregnant women(χ2=81.82,156.58,P0.05);The sensitivity of ECEE for the prenatal diagnosis of congenital heart disease for the fetuses of unselected pregnant women was not different from that of high-risk pregnant women(χ2=1.67,P0.05).Conclusions The results suggested that fetal echocardiography was highly accurate and suitable for the prenatal diagnosis of congenital heart disease. Further multicentre and prospective studies are still needed to optimize the ultrasound section and screening subjects by a cost-effectiveness analysis,and develop an operation guideline on fetal echocardiography for the prenatal diagnosis of congenital heart disease suitable for China.

The value of lipid metabolites 9,10-DOA and 11,12-EET in prenatal diagnosis of fetal heart defects

Study on Diagnostic Performance of Fetal Intelligent Navigation Echocardiography for Congenital Heart Defect

Metabolomic Profile for the Early Detection of Coronary Artery Disease by Using UPLC-QTOF/MS.

Study on the Potential Biomarkers of Maternal Urine Metabolomics for Fetus with Congenital Heart Diseases Based on Modified Gas Chromatograph-Mass Spectrometer

Biomarkers for congenital ventricular outflow tract malformations based on maternal serum lipid metabolomics analysis

Analysis of clinical characteristics and genetic testing in patients with acute fatty liver of pregnancy: a retrospective study

Proteome Profiling of Early Gestational Plasma Reveals Novel Biomarkers of Congenital Heart Disease

Maternal metabolomic profiling and congenital heart disease risk in offspring: A systematic review of observational studies

Metabolomics Identifies a Panel of Diagnostic Biomarkers for Early Human Embryonic Development Arrest.

Metabolic Profiling of Plasma in Gestational Diabetes Mellitus Using Liquid Chromatography and Q-TOF Mass Spectrometry.

Prenatal Diagnosis of Two Common Inborn Errors of Metabolism by Genetic and Mass Spectrometric Analysis of Amniotic Fluid

The Diagnostic Potential of Gut Microbiota-Derived Short-Chain Fatty Acids in Preeclampsia

Value of amniotic fluid homocysteine assay in prenatal diagnosis of combined methylmalonic acidemia and homocystinuria, cobalamin C type

The UA Doppler Index, Plasma HCY, and Cys C in Pregnancies Complicated by Congenital Heart Disease of the Fetus

Core biomarkers analysis benefit for diagnosis on human intrahepatic cholestasis of pregnancy

UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers

Application of Metabolomics to Identify Potential Biomarkers for the Early Diagnosis of Coronary Heart Disease

Amniotic fluid and urine metabolomic alterations associated with pregnant women with Down syndrome fetuses

Meta-analysis of the Value of Fetal Echocardiography for the Prenatal Diagnosis of Congenital Heart Disease

Potential candidate maternal serum miRNAs for the diagnosis of fetal congenital heart disease

Comparing amniotic fluid mass spectrometry assays and amniocyte gene analyses for the prenatal diagnosis of methylmalonic aciduria